Related Experiment Video
Updated: Sep 20, 2025

05:16
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
6.9K
Do NGS-based techniques represent a first-line testing in suspected Duchenne muscular dystrophy?
Seyed Mohammad Hosseini1, Nosratollah Alizadeh2, Abolfazl Amini3
1Laboratory Sciences Research Center Golestan University of Medical Sciences Gorgan Iran.
Clinical Case Reports
|June 6, 2022
Abstract:
Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene, which mostly affects boys. The subject was an 8-year-old child who had typical symptoms of muscle weakness. The NGS may be used as an efficient and cost-effective molecular diagnostic strategy for identifying patients with DMD.

